The human crisis in cancer: a Lancet Oncology Commission

Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation

Post-treatment exercise programme improves survival for stage II/III colon cancer

MS-553 shows promise in treating chronic lymphocytic leukaemia

BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer

Customised colorectal cancer early diagnosis programme can identify advanced adenomas and early-stage cancer

Enhancing cancer care in Africa: Patient perspectives and quality improvement

Key insights on breast cancer in Cape Verde

Addressing cancer control challenges in Africa

Liso-cel in r/r follicular lymphoma shows durable 3-year responses and favourable long-term safety

TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML

Consolidation treatment delays do not compromise survival in MRD-negative adult ALL